Switch View
© BusinessWire
13.11.2025
ISIN: IE00BGH1M568
Perrigo Company PLC
PRGO
LISTED
NYSE
Securities Fraud Investigation Into Perrigo Company plc (PRGO) Announced – Shareholders Who Lost Money Urged To Contact The Law Offices of Frank R. Cruz
News Preview
The Law Offices of Frank R. Cruz announces an investigation of Perrigo Company plc (“Perrigo” or the “Company”) (NYSE: PRGO) on behalf of investors concerning the Company’s possible violations of federal securities laws.
IF YOU ARE AN INVESTOR WHO LOST MONEY ON PERRIGO COMPANY PLC (PRGO), CLICK HERE TO INQUIRE ABOUT POTENTIALLY PURSUING A CLAIM...
Themefolio
Profiler
Peergroup
© Newsfile
13.11.2025
ISIN: US60855R1005
Molina Healthcare Inc
MOH
LISTED
NYSE
MOH DEADLINE NOTICE: ROSEN, LEADING TRIAL ATTORNEYS, Encourages Molina Healthcare, Inc. Investors to Secure Counsel Before Important Deadline in Securities Class Action - MOH
News Preview
New York, New York--(Newsfile Corp. - November 12, 2025) - WHY: Rosen Law Firm, a global investor rights law firm, reminds purchasers of securities of Molina Healthcare, Inc. (NYSE: MOH) between February 5, 2025 and July 23, 2025, both dates inclusive (the "Class Period"), of the important December 2, 2025 lead plaintiff deadline.SO WHAT: If you pu...
Themefolio
Profiler
Peergroup
© Newsfile
13.11.2025
ISIN: US23282W6057
Cytokinetics Inc
CYTK
LISTED
NASDAQ
ROSEN, TOP RANKED INVESTOR COUNSEL, Encourages Cytokinetics, Inc. Investors to Secure Counsel Before Important November 17 Deadline in Securities Class Action - CYTK
News Preview
New York, New York--(Newsfile Corp. - November 12, 2025) - WHY: Rosen Law Firm, a global investor rights law firm, reminds purchasers of common stock of Cytokinetics, Inc. (NASDAQ: CYTK) between December 27, 2023 and May 6, 2025, both dates inclusive (the "Class Period"), of the important November 17, 2025 lead plaintiff deadline.SO WHAT: If y...
Themefolio
Profiler
Peergroup
Worth to know
20.10.2025
Short Selling Radar
USA, Europe, Asia
Track Short Selling Activities worldwide
Knowing what matters
Short sale statistics, hedge fund activities and much more user-friendly information
© Newsfile
13.11.2025
ISIN: US4718712023
Jasper Therapeutics, Inc.
JSPR
LISTED
NASDAQ
JSPR DEADLINE ALERT: ROSEN, A LONGSTANDING FIRM, Encourages Jasper Therapeutics, Inc. Investors to Secure Counsel Before Important November 18 Deadline in Securities Class Action - JSPR
News Preview
New York, New York--(Newsfile Corp. - November 12, 2025) - WHY: Rosen Law Firm, a global investor rights law firm, reminds purchasers of securities of Jasper Therapeutics, Inc. (NASDAQ: JSPR) between November 30, 2023 and July 3, 2025, both dates inclusive (the "Class Period"), of the important November 18, 2025 lead plaintiff deadline.SO WHAT...
Themefolio
Profiler
Peergroup
Swarmalpha i/o · The Event Futures Prediction X
20.10.2025
© BusinessWire
13.11.2025
ISIN: US98956P1021
Zimmer Biomet Holdings Inc
ZBH
LISTED
NYSE
Securities Fraud Investigation Into Zimmer Biomet Holdings, Inc. (ZBH) Announced – Shareholders Who Lost Money Urged To Contact The Law Offices of Frank R. Cruz
News Preview
The Law Offices of Frank R. Cruz announces an investigation of Zimmer Biomet Holdings, Inc. (“Zimmer” or the “Company”) (NYSE: ZBH) on behalf of investors concerning the Company’s possible violations of federal securities laws.
IF YOU ARE AN INVESTOR WHO LOST MONEY ON ZIMMER BIOMET HOLDINGS, INC. (ZBH), CLICK HERE TO INQUIRE ABOUT POTENTIALLY PU...
Themefolio
Profiler
Peergroup
© BusinessWire
13.11.2025
ISIN: AU000000TLX2
Telix Pharmaceuticals Ltd
TLX
LISTED
ASX
Law Offices of Howard G. Smith Encourages Telix Pharmaceuticals Limited (TLX) Shareholders To Inquire About Securities Fraud Class Action
News Preview
Law Offices of Howard G. Smith announces that a class action lawsuit has been filed on behalf of investors who purchased Telix Pharmaceuticals Limited (“Telix” or the “Company”) (NASDAQ: TLX) securities between February 21, 2025 and August 28, 2025, inclusive (the “Class Period”). Telix investors have until January 9, 2025 to file a lead plaintiff...
Themefolio
Profiler
Peergroup
© Newsfile
13.11.2025
ISIN: US60855R1005
Molina Healthcare Inc
MOH
LISTED
NYSE
MOH SHAREHOLDER ACTION REMINDER: Faruqi & Faruqi, LLP Investigates Claims on Behalf of Investors of Molina Healthcare
News Preview
Faruqi & Faruqi, LLP Securities Litigation Partner James (Josh) Wilson Encourages Investors Who Suffered Losses In Molina To Contact Him Directly To Discuss Their OptionsIf you purchased or acquired securities in Molina between February 5, 2025 and July 23, 2025 and would like to discuss your legal rights, call Faruqi & Faruqi partner Josh...
Themefolio
Profiler
Peergroup
© Newsfile
13.11.2025
ISIN: US4718712023
Jasper Therapeutics, Inc.
JSPR
LISTED
NASDAQ
INVESTOR DEADLINE APPROACHING: Faruqi & Faruqi, LLP Investigates Claims on Behalf of Investors of Jasper
News Preview
Faruqi & Faruqi, LLP Securities Litigation Partner James (Josh) Wilson Encourages Investors Who Suffered Losses In Jasper To Contact Him Directly To Discuss Their OptionsIf you suffered losses in Jasper between November 30, 2023 and July 3, 2025 and would like to discuss your legal rights, call Faruqi & Faruqi partner Josh Wilson directly a...
Themefolio
Profiler
Peergroup
© BusinessWire
13.11.2025
ISIN: US1710774076
Niagen Bioscience Inc
CDXC
LISTED
NASDAQ
Niagen Bioscience Announces Results from First-Ever Randomized Controlled Trial Exploring Niagen (Patented Nicotinamide Riboside, NR) Supplementation in Long COVID
News Preview
Niagen Bioscience, Inc. (NASDAQ: NAGE), the global authority on NAD+ (nicotinamide adenine dinucleotide) with a focus on the science of healthy aging, today shared promising results from the first-of-its-kind clinical trial published today in The Lancet peer-reviewed journal eClinicalMedicine demonstrating that daily supplementation with Niagen®,...
Themefolio
Profiler
Peergroup
© Newsfile
13.11.2025
ISIN: US0718131099
Baxter International, Inc.
BAX
LISTED
NYSE
ROSEN, A LEADING INVESTOR RIGHTS LAW FIRM, Encourages Baxter International Inc. Investors to Secure Counsel Before Important Deadline in Securities Class Action - BAX
News Preview
New York, New York--(Newsfile Corp. - November 12, 2025) - WHY: Rosen Law Firm, a global investor rights law firm, reminds purchasers of common stock of Baxter International Inc. (NYSE: BAX) between February 23, 2022 and July 30, 2025, both dates inclusive (the "Class Period"), of the important December 15, 2025 lead plaintiff deadline.SO WHAT...
Themefolio
Profiler
Peergroup
© Newsfile
13.11.2025
ISIN: US0021202025
Atyr Pharma, Inc.
ATYR
LISTED
NASDAQ
ROSEN, A TRUSTED AND LEADING LAW FIRM, Encourages aTyr Pharma, Inc. Investors to Secure Counsel Before Important Deadline in Securities Class Action - ATYR
News Preview
New York, New York--(Newsfile Corp. - November 12, 2025) - WHY: Rosen Law Firm, a global investor rights law firm, reminds purchasers of common stock of aTyr Pharma, Inc. (NASDAQ: ATYR) between January 16, 2025 and September 12, 2025, both dates inclusive (the "Class Period"), of the important December 8, 2025 lead plaintiff deadline.SO WHAT:...
Themefolio
Profiler
Peergroup
© Newsfile
13.11.2025
ISIN: US0718131099
Baxter International, Inc.
BAX
LISTED
NYSE
INVESTOR DEADLINE APPROACHING: Faruqi & Faruqi, LLP Investigates Claims on Behalf of Investors of Baxter International
News Preview
Faruqi & Faruqi, LLP Securities Litigation Partner James (Josh) Wilson Encourages Investors Who Suffered Losses In Baxter To Contact Him Directly To Discuss Their OptionsIf you purchased or acquired securities in Baxter between February 23, 2022 and July 30, 2025 and would like to discuss your legal rights, call Faruqi & Faruqi partner Josh...
Themefolio
Profiler
Peergroup
Advertisment
20.10.2025
© Newsfile
13.11.2025
ISIN: US23282W6057
Cytokinetics Inc
CYTK
LISTED
NASDAQ
INVESTOR DEADLINE APPROACHING: Faruqi & Faruqi, LLP Investigates Claims on Behalf of Investors of Cytokinetics
News Preview
Faruqi & Faruqi, LLP Securities Litigation Partner James (Josh) Wilson Encourages Investors Who Suffered Losses In Cytokinetics To Contact Him Directly To Discuss Their OptionsIf you suffered losses in Cytokinetics between December 27, 2023 and May 6, 2025 and would like to discuss your legal rights, call Faruqi & Faruqi partner Josh Wilson...
Themefolio
Profiler
Peergroup
© Newsfile
12.11.2025
ISIN: US4577301090
Inspire Medical Systems Inc
INSP
LISTED
NYSE
ROSEN, A RESPECTED AND LEADING FIRM, Encourages Inspire Medical Systems, Inc. Investors to Secure Counsel Before Important Deadline in Securities Class Action - INSP
News Preview
New York, New York--(Newsfile Corp. - November 12, 2025) - WHY: Rosen Law Firm, a global investor rights law firm, announces a class action lawsuit on behalf of purchasers of common stock of Inspire Medical Systems, Inc. (NYSE: INSP) between August 6, 2024 and August 4, 2025, both dates inclusive (the "Class Period"). A class action lawsuit ha...
Themefolio
Profiler
Peergroup
© PR Newswire
12.11.2025
ISIN: US50015M1099
Kodiak Sciences Inc
KOD
LISTED
NASDAQ
Kodiak Sciences to Present at Upcoming Investor Conferences
News Preview
PALO ALTO, Calif., Nov. 12, 2025 /PRNewswire/ -- Kodiak Sciences Inc. (Nasdaq: KOD), a precommercial retina focused biotechnology company committed to researching, developing and commercializing transformative therapeutics, announced today that Victor Perlroth, M.D., Chief Executive Officer, will present at the f...
Themefolio
Profiler
Peergroup
© BusinessWire
12.11.2025
ISIN: US4577301090
Inspire Medical Systems Inc
INSP
LISTED
NYSE
INSP Investors Have Opportunity to Lead Inspire Medical Systems, Inc. Securities Fraud Lawsuit with the Schall Law Firm
News Preview
The Schall Law Firm, a national shareholder rights litigation firm, reminds investors of a class action lawsuit against Inspire Medical Systems, Inc. (“Inspire” or “the Company”) (NYSE: INSP) for violations of §§10(b) and 20(a) of the Securities Exchange Act of 1934 and Rule 10b-5 promulgated thereunder by the U.S. Securities and Exchange Commissi...
Themefolio
Profiler
Peergroup
© PR Newswire
12.11.2025
ISIN: US05352A1007
Avantor Inc
AVTR
LISTED
NYSE
AVTR Investors Have Opportunity to Lead Avantor, Inc. Securities Fraud Lawsuit
News Preview
NEW YORK, Nov. 12, 2025 /PRNewswire/ --
Why: Rosen Law Firm, a global investor rights law firm, reminds purchasers of common stock of Avantor, Inc. (NYSE: AVTR)...
Themefolio
Profiler
Peergroup
© BusinessWire
12.11.2025
ISIN: US2274831047
Cross Country Healthcare Inc
CCRN
LISTED
NASDAQ
Cross Country Healthcare Announces Third Quarter 2025 Financial Results
News Preview
Cross Country Healthcare, Inc. (the Company) (Nasdaq: CCRN) today announced financial results for its third quarter ended September 30, 2025.
Selected Financial Information:
Variance
Variance
Q3 2025 vs
Q3 2025 vs
Dollars are in thousands, except per share amounts
Q3...
Themefolio
Profiler
Peergroup
© Globe Newswire
12.11.2025
ISIN: US03675P1021
Anteris Technologies Global Corp.
AVR
LISTED
NASDAQ
Anteris Announces Results for the Third Quarter of 2025
News Preview
Anteris Technologies (NASDAQ: AVR, ASX: AVR) reports financial results for the quarter ended September 30, 2025, and provides a corporate update....
Themefolio
Profiler
Peergroup
© Newsfile
12.11.2025
ISIN: US05352A1007
Avantor Inc
AVTR
LISTED
NYSE
INVESTOR DEADLINE APPROACHING: Faruqi & Faruqi, LLP Investigates Claims on Behalf of Investors of Avantor
News Preview
Faruqi & Faruqi, LLP Securities Litigation Partner James (Josh) Wilson Encourages Investors Who Suffered Losses In Avantor To Contact Him Directly To Discuss Their OptionsIf you purchased or acquired securities in Avantor between March 5, 2024 and October 28, 2025 and would like to discuss your legal rights, call Faruqi & Faruqi partner Jos...
Themefolio
Profiler
Peergroup
© Newsfile
12.11.2025
ISIN: KY61559X1045
MoonLake Immunotherapeutics
MLTX
LISTED
NASDAQ
Levi & Korsinsky Notifies MoonLake Immunotherapeutics (MLTX) Investors - Lead Plaintiff Deadline on December 15, 2025
News Preview
New York, New York--(Newsfile Corp. - November 12, 2025) - If you suffered a loss on your MoonLake Immunotherapeutics (NASDAQ: MLTX) investment and want to learn about a potential recovery under the federal securities laws, follow the link below for more information:https://zlk.com/pslra-1/moonlake-lawsuit-submission-form?prid=177026&wire=5&...
Themefolio
Profiler
Peergroup
© Newsfile
12.11.2025
ISIN: US0021202025
Atyr Pharma, Inc.
ATYR
LISTED
NASDAQ
Securities Lawsuit Alert: aTyr Pharma, Inc. (ATYR) Investors - Contact Levi & Korsinsky Before December 8, 2025
News Preview
New York, New York--(Newsfile Corp. - November 12, 2025) - If you suffered a loss on your aTyr Pharma, Inc. (NASDAQ: ATYR) investment and want to learn about a potential recovery under the federal securities laws, follow the link below for more information:https://zlk.com/pslra-1/atyr-pharma-inc-lawsuit-submission-form?prid=177024&wire=5&ut...
Themefolio
Profiler
Peergroup
© Newsfile
12.11.2025
ISIN: US4577301090
Inspire Medical Systems Inc
INSP
LISTED
NYSE
INVESTOR DEADLINE APPROACHING: Faruqi & Faruqi, LLP Investigates Claims on Behalf of Investors of Inspire Medical Systems
News Preview
Faruqi & Faruqi, LLP Securities Litigation Partner James (Josh) Wilson Encourages Investors Who Suffered Losses In Inspire Medical To Contact Him Directly To Discuss Their OptionsIf you purchased or acquired securities in Inspire Medical between August 6, 2024 and August 4, 2025 and would like to discuss your legal rights, call Faruqi & Far...
Themefolio
Profiler
Peergroup
© Newsfile
12.11.2025
ISIN: US4577301090
Inspire Medical Systems Inc
INSP
LISTED
NYSE
INSP INVESTOR ALERT: Inspire Medical Systems, Inc. Investors with Substantial Losses Have Opportunity to Lead Class Action Lawsuit
News Preview
San Diego, California--(Newsfile Corp. - November 12, 2025) - Robbins Geller Rudman & Dowd LLP announces that purchasers or acquirers of Inspire Medical Systems, Inc. (NYSE: INSP) common stock between August 6, 2024 and August 4, 2025, both dates inclusive (the "Class Period"), have until January 5, 2026 to seek appointment as lead plaintiff of...
Themefolio
Profiler
Peergroup
© BusinessWire
12.11.2025
ISIN: CA25253X2077
DiaMedica Therapeutics, Inc.
DMAC
LISTED
NASDAQ
DiaMedica Therapeutics Reports Third Quarter 2025 Financial Results and Provides Business Highlights
News Preview
DiaMedica Therapeutics Inc. (Nasdaq: DMAC), a clinical-stage biopharmaceutical company focused on developing novel treatments for preeclampsia (PE), fetal growth restriction and acute ischemic stroke (AIS), today provided a business update and reported financial results for the third quarter ended September 30, 2025. Management will host a confere...
Themefolio
Profiler
Peergroup
© Newsfile
12.11.2025
ISIN: CA76134J2065
Restart Life Sciences Corp
HEAL
LISTED
CSE
Restart Life Sciences Announces Private Placement Financing
News Preview
Vancouver, British Columbia--(Newsfile Corp. - November 12, 2025) - Restart Life Sciences Corp. (CSE: HEAL) (FSE: HN30) (OTC Pink: NMLSF) ("Restart Life" or the "Company") is pleased to announce a non-brokered private placement of up to 10,000,000 units in the capital of the Company (each, a "Unit") at a price of CAD $0.10 per Unit for aggregate gr...
Themefolio
Profiler
Peergroup
© Newsfile
12.11.2025
ISIN: KY61559X1045
MoonLake Immunotherapeutics
MLTX
LISTED
NASDAQ
ROSEN, LEADING TRIAL ATTORNEYS, Encourages MoonLake Immunotherapeutics Investors to Secure Counsel Before Important Deadline in Securities Class Action - MLTX
News Preview
New York, New York--(Newsfile Corp. - November 12, 2025) - WHY: Rosen Law Firm, a global investor rights law firm, reminds purchasers of common stock of MoonLake Immunotherapeutics (NASDAQ: MLTX) between March 10, 2024 and September 29, 2025, both dates inclusive (the "Class Period"), of the important December 15, 2025 lead plaintiff deadline....
Themefolio
Profiler
Peergroup
© BusinessWire
12.11.2025
ISIN: US80706P1030
Scholar Rock Holding Corp
SRRK
LISTED
NASDAQ
Scholar Rock Reports New Employee Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
News Preview
Scholar Rock (NASDAQ: SRRK; the “Company”) today announced that the company granted inducement equity awards covering an aggregate of 30,000 shares of its common stock to 1 newly hired employee, consisting of inducement stock options to purchase an aggregate of 17,143 shares of common stock and inducement restricted stock units, covering an aggreg...
Themefolio
Profiler
Peergroup
Long/Short | Fractionals | Margin | Hedge · 4 powerful Trading App | MT4.MT5.ACTIVTRADER | TradingViewplus
More information, click here
More sector specific news
Your Press Release is missing or you want share news over GICS11? Drop us a line.
